Ronilda D’Cunha

585 total citations
27 papers, 338 citations indexed

About

Ronilda D’Cunha is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Ronilda D’Cunha has authored 27 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Ronilda D’Cunha's work include Psoriasis: Treatment and Pathogenesis (5 papers), Inflammatory Bowel Disease (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ronilda D’Cunha is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (5 papers), Inflammatory Bowel Disease (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ronilda D’Cunha collaborates with scholars based in United States, Germany and Israel. Ronilda D’Cunha's co-authors include Nattawut Leelakanok, Guohua An, Daryl J. Murry, Yinuo Pang, Peizhi Li, Patricia Winokur, Jun Zhang, Demet Nalbant, Sohyun Bae and Kori Wallace and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Annals of the Rheumatic Diseases and Journal of the American Academy of Dermatology.

In The Last Decade

Ronilda D’Cunha

26 papers receiving 336 citations

Peers

Countries citing papers authored by Ronilda D’Cunha

Since Specialization

Citations

This map shows the geographic impact of Ronilda D’Cunha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronilda D’Cunha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronilda D’Cunha more than expected).

Fields of papers citing papers by Ronilda D’Cunha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronilda D’Cunha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronilda D’Cunha. The network helps show where Ronilda D’Cunha may publish in the future.

Co-authorship network of co-authors of Ronilda D’Cunha

This figure shows the co-authorship network connecting the top 25 collaborators of Ronilda D’Cunha. A scholar is included among the top collaborators of Ronilda D’Cunha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronilda D’Cunha. Ronilda D’Cunha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and Safety of ABBV ‐154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo‐Controlled Trial 2025 ·Arthritis & Rheumatology ·Frank Buttgereit, Atul Singhal, Alan Kivitz, Edit Drescher, (unknown), (unknown), J. Anderson, Ronilda D’Cunha, (unknown), (unknown), Julie Parmentier, Romy Christmann, Dilek Arikan, Howard Amital	0
2	Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial 2025 ·Arthritis & Rheumatology ·Robert Spiera, Valérie Devauchelle‐Pensec, Claire Owen, Federico Díaz‐González, Tsutomu Takeuchi, Edit Drescher, J. Anderson, Dilek Arikan, Ronilda D’Cunha, Julie Parmentier, Denise Kruzikas, (unknown), Yang� Yang, (unknown), Frank Buttgereit	2
3	Population Pharmacokinetic and Exposure–Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis 2024 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), (unknown), Ahmed A. Suleiman, Ronilda D’Cunha, Sven Mensing, (unknown), Yinuo Pang	5
4	Evaluation of the Effect of Risankizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease 2024 ·Clinical Pharmacokinetics ·Ronilda D’Cunha, (unknown), Jasmina Kalabic, (unknown), Adi Lahat, Yinuo Pang	1
5	Risankizumab: Mechanism of action, clinical and translational science 2024 ·Clinical and Translational Science ·Yinuo Pang, Ronilda D’Cunha, (unknown), Geertruida M. Veldman, Valerie Pivorunas, Kori Wallace	20
6	Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults 2024 ·Clinical Pharmacology in Drug Development ·Mohamed‐Eslam F. Mohamed, Yuli Qian, Ronilda D’Cunha, (unknown), (unknown), (unknown), Kinjal Hew, Wei Liu	2
7	A first‐in‐human study of the novel immunology antibody–drug conjugate, ABBV‐3373, in healthy participants 2023 ·British Journal of Clinical Pharmacology ·Ronilda D’Cunha, H. Küpper, Dilek Arikan, (unknown), David Carter, Jonas Blaes, Melanie C. Ruzek, Yinuo Pang	6
8	43882 Pharmacokinetics, Safety, and Efficacy of Cedirogant (ABBV-157) in Patients With Moderate-to- Severe Plaque Psoriasis 2023 ·Journal of the American Academy of Dermatology ·Ronilda D’Cunha, (unknown), Laura K. Ferris, Ann Eldred, (unknown), (unknown), S. Jazayeri, Howard Sofen, (unknown), Mohamed‐Eslam F. Mohamed	1
9	Clinical Bridging From Prefilled Syringe to On-body Injector for Risankizumab in Crohn's Disease 2023 ·Clinical Therapeutics ·Yinuo Pang, Ronilda D’Cunha, Afroz S. Mohammad, (unknown), (unknown), Jasmina Kalabic, (unknown), Sai Nudurupati, Kori Wallace, (unknown), (unknown), (unknown), (unknown), Patrick Marroum	5
10	Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double‐Blind, Active‐Controlled Proof‐of‐Concept Phase IIa Trial 2022 ·Arthritis & Rheumatology ·Frank Buttgereit, Jacob Aelion, Bernadette Rojkovich, (unknown), Su Chen, Yang� Yang, Dilek Arikan, Ronilda D’Cunha, Yinuo Pang, H. Küpper, Timothy R. D. J. Radstake, Howard Amital	31
11	Population Pharmacokinetic and Exposure–Response Analyses for Efficacy and Safety of Risankizumab in Patients With Active Crohn's Disease 2022 ·Clinical Pharmacology & Therapeutics ·Ahmed A. Suleiman, (unknown), Sumit Bhatnagar, Ronilda D’Cunha, (unknown), Yinuo Pang	16
12	A Systematic Review and Meta-analysis of Isoniazid Pharmacokinetics in Healthy Volunteers and Patients with Tuberculosis 2020 ·Clinical Therapeutics ·(unknown), Ronilda D’Cunha, Peizhi Li, Mohammad H. Al‐Shaer, Wael A. Alghamdi, Guohua An, Charles A. Peloquin	21
13	A Systematic Review and Meta-analysis of Isoniazid Pharmacokinetics in Healthy Volunteers and Patients with Tuberculosis 2020 ·Zenodo (CERN European Organization for Nuclear Research) ·(unknown), Ronilda D’Cunha, Peizhi Li, Mohammad H. Al‐Shaer, Wael A. Alghamdi, Guohua An, Charles A. Peloquin	1
14	Target-mediated disposition population pharmacokinetics model of erythropoietin in premature neonates following multiple intravenous and subcutaneous dosing regimens 2019 ·European Journal of Pharmaceutical Sciences ·Ronilda D’Cunha, Robert L. Schmidt, John A. Widness, Donald M. Mock, Xiaoyu Yan, Gretchen A. Cress, (unknown), Peter Veng‐Pedersen, Guohua An	7
15	Development and validation of a simple, fast, and sensitive LC/MS/MS method for the quantification of oxfendazole in human plasma and its application to clinical pharmacokinetic study 2019 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Sohyun Bae, Ronilda D’Cunha, Patricia Winokur, Guohua An	13
16	Nilotinib Alters the Efflux Transporter-Mediated Pharmacokinetics of Afatinib in Mice 2019 ·Journal of Pharmaceutical Sciences ·Ronilda D’Cunha, Daryl J. Murry, Guohua An	4
17	A Review of Regulatory Guidance for Conducting Hepatic Impairment Studies: A Case Study in Oncology 2018 ·(unknown), Ronilda D’Cunha	6
18	Effect of 5,7-dimethoxyflavone on Bcrp1-mediated transport of sorafenib in vitro and in vivo in mice 2018 ·European Journal of Pharmaceutical Sciences ·Sohyun Bae, Ronilda D’Cunha, Jie Shao, Guohua An	11
19	A systematic review and meta-analysis of the association between vitamin A intake, serum vitamin A, and risk of liver cancer 2018 ·Nutrition and Health ·Nattawut Leelakanok, Ronilda D’Cunha, Grerk Sutamtewagul, Marin L. Schweizer	7
20	TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp‐ and BCRP‐mediated efflux 2016 ·Biopharmaceutics & Drug Disposition ·Ronilda D’Cunha, (unknown), Daryl J. Murry, Guohua An	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact